Lluís Ribas de Pouplana
Corporate Officer/Principal presso ICREA
Posizioni attive di Lluís Ribas de Pouplana
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ICREA | Corporate Officer/Principal | - | - |
Storia della carriera di Lluís Ribas de Pouplana
Precedenti posizioni note di Lluís Ribas de Pouplana
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Corporate Officer/Principal | 01/01/1997 | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/1997 | 01/01/1997 |
Omnia Molecular SL
 Omnia Molecular SL Pharmaceuticals: MajorHealth Technology Omnia Molecular SL engaged in the designing of anti-infective pharmaceuticals. The firm used its proprietary platform to synthesize and develop novel drugs targeted at infections such as mycosis and tuberculosis. The company was founded by Lluís Ribas de Pouplana and Juan Gargallo Costa in 2005 and was headquartered in Barcelona, Spain. | Direttore Tecnico/Scientifico/R&S | 01/01/2005 | - |
| Fondatore | 01/01/2005 | - |
Formazione di Lluís Ribas de Pouplana
| University of Barcelona | Undergraduate Degree |
| The University of Edinburgh | Doctorate Degree |
Statistiche
Distribuzione geografica
| Spagna | 4 |
| Stati Uniti | 3 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 5 |
| Health Technology | 2 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Omnia Molecular SL
Omnia Molecular SL Pharmaceuticals: MajorHealth Technology Omnia Molecular SL engaged in the designing of anti-infective pharmaceuticals. The firm used its proprietary platform to synthesize and develop novel drugs targeted at infections such as mycosis and tuberculosis. The company was founded by Lluís Ribas de Pouplana and Juan Gargallo Costa in 2005 and was headquartered in Barcelona, Spain. | Health Technology |
